National

PM holds review meeting for Covid-19 vaccine delivery

Our Bureau New Delhi | Updated on November 21, 2020 Published on November 21, 2020

Prime Minister Narendra Modi presiding over the review meeting   -  Twitter via @narendramodi

Step are being taken to ensure that vaccines reach all locations, and every person according to prioritisation principles

Covid-19 vaccines that prove their efficacy in Phase III trials may be given emergency use authorisation by the country’s drug regulator, a review meeting on Covid-19 measures chaired by Prime Minister Narendra Modi on Friday night was told.

The meeting was also told that many countries, such as Bangladesh, Myanmar, Qatar, Bhutan, Switzerland, Bahrain, Austria and South Korea have shown interest in partnering for development of Indian vaccines and their subsequent use. Five vaccines are in advanced stages of development in the country, of which four are in Phase 2/3 and one in Phase 1/2 stages, an official release said.

Also read: ‘PPP model can ensure access to Covid-19 vaccine’

To administer the vaccine at the first available opportunity, database of healthcare and frontline workers, augmentation of cold chains and procurement of syringes and needles are in advanced stages of preparation. Apart from enhancing the vaccine supply chain, non-vaccine supplies are also being escalated.

The government also plans to involve medical and nursing students in training and vaccine administration, the release said.

Also read: EU official: Two vaccines could be authorised soon

Steps are being taken to ensure that vaccines reach every location and person according to the prioritisation principles. The digital platform for vaccine administration and distribution is ready and test runs are underway in partnership with State- and district-level stakeholders, the release said.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on November 21, 2020
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.